We are excited to introduce Dr. Jerald Radich, our featured faculty member at SCHD 2023!
Faculty Bio
Dr. Jerald Radich is a medical oncologist specializing in the molecular genetics of leukemia. He studies genes and other molecules that signal treatment response, progression, and relapse.
Dr. Radich specializes in developing methods for improving the detection and treatment of chronic and acute myeloid leukemias (CMLs and AMLs). His team investigates how specific genetic variants influence treatment responses and outcomes. By analyzing these variants, Doctors could select the most effective treatment for their patients.
In addition, Dr. Radich directs Fred Hutch’s Molecular Oncology Lab, which provides high-quality molecular testing for clinical cancer researchers.
Click here to learn more about Dr. Jerald Radich.
SCHD 2023
The Summit on Healthcare Disparities, or SCHD 2023, promotes collaboration and partnerships across disciplines. Partnerships such as these generate new research and treatment paradigms, reduce cancer disparities, and improve patient outcomes.
Watch the video to learn more about Dr. Radich's experience at SCHD 2023!
About Binaytara Foundation
Founded in 2007, Binaytara Foundation (BTF) is an international non-profit organization dedicated to improving access to cancer care. Through educational and innovative approaches, BTF aims to eliminate socioeconomic barriers in the field of oncology and hematology.
Binaytara Foundation organizes a significant number of hematology and oncology conferences on a regional, national, and international basis. Binaytara Foundation is most noted for constructing a 200-bed state-of-the-art cancer hospital in Janakpur, Nepal. BTF also assisted in building the first bone marrow transplant center in Kathmandu, Nepal, and palliative care initiatives in South Asia.
Please visit the organization's website to learn more about the Binaytara Foundation's impact missions.